Most Recent
Westpac unit RAMS flags fraud claim in franchisee class action
Westpac's shuttered home loan unit RAMS may hit back at franchisees' class action claims by alleging they made misrepresentations and provided fraudulent documents.
Liquidators settle with Grant Thornton, Moore Stephens over Linchpin audits
Linchpin Capital liquidators have resolved their case against Grant Thornton and Moore Stephens, a year after a court found the evidence on its face established a claim against the auditors.
IP sole practitioner makes the leap to Dentons
A founder and former principal at a Sydney intellectual property firm has made the switch to Dentons, filling out the  firm's Australasian patents team. 
S&P class action judge to hear fight over evidence of fraud
A class action over S&P’s rosy ratings on risky financial products faces a preliminary fight over the relevance of expert evidence that seeks to prove fraud on the part of the ratings agency.
KFC tries to avoid ‘hypothetical’ class action trial over rest breaks
Fast food giant KFC has argued an initial trial in an underpayments class action could result in an “entirely hypothetical” finding unless it also deals with the claims of several sample group members. 
McDonald’s rest breaks class action ‘gone backwards’, court told
A class action against McDonald’s alleging workers were not given mandatory rest breaks has “gone backwards” after the fast food giant withdrew previously agreed facts, a court has heard. 
Olam Agri offers to divest Queensland Cotton gin to acquire Namoi Cotton
Olam Agri Holdings has offered to divest its Queensland cotton gin and a 20 per cent holding in a leading Australian cotton classing company to win approval for its takeover of Namoi Cotton.
Law firm wins reversal of $16M judgment in client’s breach of duty case
An appeals court has overturned a $16 million judgment against a law firm, finding it did not breach its duties when acting for a lender that provided financing to a client.
Biotech files new patent suit against Samsung Bioepis over Crohn’s drug
Samsung Bioepis can't get indemnity costs from Janssen Biotech after it surrendered patents for Crohn’s disease drug Stelara and filed a fresh case based on new patents for the drug. 
Class action over $85M Clydesdale development loses injunction bid
A class action by frustrated buyers over the $85 million sale of a Sydney development has failed to prevent the sale of lots, with a judge finding the class action's claims lack evidence.